• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Samba II PCR 检测在孕妇 COVID-19 中的应用:一项回顾性队列研究和文献综述。

Samba II PCR testing for COVID-19 in pregnant women: a retrospective cohort study and literature review.

机构信息

Department of Obstetrics & Gynaecology, Rosie Maternity Hospital, Cambridge, CB2 0SQ, UK.

Department of Anaesthesia, Cambridge University NHS Hospitals Foundation Trust, Cambridge, CB2 0QQ, UK.

出版信息

BMC Pregnancy Childbirth. 2021 Mar 17;21(1):212. doi: 10.1186/s12884-021-03653-4.

DOI:10.1186/s12884-021-03653-4
PMID:33731037
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7968137/
Abstract

BACKGROUND

Asymptomatic carriage of COVID-19 in pregnant women has been reported and could lead to outbreaks in maternity units. We sought to ascertain the impact of rapid isothernal nucleic acid based testing for COVID-19 in an unselected cohort of pregnant women attending our maternity unit. We also assessed the correlation between community prevalence and asymptomatic carriage.

METHODS

Data for the retrospective cohort study were collected from a large UK tertiary maternity unit over a 4-week period using computerised hospital records. Literature searches were performed across multiple repositories. COVID-19 prevalence was extracted from online repositories.

RESULTS

Nasopharyngeal and oropharyngeal swabs were obtained from 457/465 (98%) women during the study period. The median turnaround time for results was 5.3 h (interquartile range (IQR) 2.6-8.9 h), with 92% of the results returned within 24 h. In our cohort, only one woman tested positive, giving a screen positive rate of 0.22% (1/457; 95% CI: 0.04-1.23%). One woman who tested negative developed a fever postnatally following discharge but was lost to follow-up. From our literature review, we did not find any correlation between asymptomatic carriage in pregnant women and the reported regional prevalence of COVID-19.

CONCLUSIONS

Testing using the SAMBA-II machine was acceptable to the vast majority of pregnant women requiring admission and had a low turnaround time. Asymptomatic carriage is low, but not correlated to community prevalence rates. Screening pregnant women on admission will remain an important component in order to minimise nosocomial infection.

摘要

背景

已有报道称,COVID-19 在孕妇中的无症状携带情况,这可能导致产科病房爆发疫情。我们旨在确定在未选择的孕妇队列中使用等温核酸快速检测 COVID-19 的影响。我们还评估了社区流行率与无症状携带之间的相关性。

方法

回顾性队列研究的数据来自英国一家大型三级产科医院在四周内使用计算机化的医院记录收集。对多个存储库进行了文献检索。从在线存储库中提取 COVID-19 流行率。

结果

在研究期间,从 457/465(98%)名妇女中获得了鼻咽和口咽拭子。结果的中位数周转时间为 5.3 小时(四分位距(IQR)2.6-8.9 小时),92%的结果在 24 小时内返回。在我们的队列中,仅 1 名妇女检测呈阳性,阳性检出率为 0.22%(457 例;95%CI:0.04-1.23%)。一名检测阴性的妇女产后出院后发烧,但失访。从我们的文献综述中,我们没有发现孕妇无症状携带与报告的 COVID-19 区域流行率之间存在任何相关性。

结论

使用 SAMBA-II 机器进行检测,绝大多数需要住院的孕妇都能接受,且周转时间短。无症状携带率低,但与社区流行率无关。入院时对孕妇进行筛查仍将是减少医院感染的重要组成部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7873/7972193/30b416ab9970/12884_2021_3653_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7873/7972193/d08039c51cc5/12884_2021_3653_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7873/7972193/ef3ff886bd5d/12884_2021_3653_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7873/7972193/30b416ab9970/12884_2021_3653_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7873/7972193/d08039c51cc5/12884_2021_3653_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7873/7972193/ef3ff886bd5d/12884_2021_3653_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7873/7972193/30b416ab9970/12884_2021_3653_Fig3_HTML.jpg

相似文献

1
Samba II PCR testing for COVID-19 in pregnant women: a retrospective cohort study and literature review.Samba II PCR 检测在孕妇 COVID-19 中的应用:一项回顾性队列研究和文献综述。
BMC Pregnancy Childbirth. 2021 Mar 17;21(1):212. doi: 10.1186/s12884-021-03653-4.
2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) universal screening in gravids during labor and delivery.在分娩期间对孕妇进行严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的全面筛查。
Eur J Obstet Gynecol Reprod Biol. 2021 Jan;256:400-404. doi: 10.1016/j.ejogrb.2020.11.069. Epub 2020 Dec 1.
3
Questionnaire-based vs universal PCR testing for SARS-CoV-2 in women admitted for delivery.基于问卷的与通用 PCR 检测在因分娩而住院的女性中用于 SARS-CoV-2 的比较。
Birth. 2021 Mar;48(1):96-103. doi: 10.1111/birt.12520. Epub 2020 Dec 1.
4
Initial findings of universal screening for SARS-CoV-2 in women admitted for delivery in North Wales: a prospective multicentre cohort study.北威尔士分娩产妇中 SARS-CoV-2 普遍筛查的初步发现:一项前瞻性多中心队列研究。
J Obstet Gynaecol. 2022 Jul;42(5):1122-1125. doi: 10.1080/01443615.2021.2011179. Epub 2022 Jan 7.
5
SARS-COV-2 infection in pregnant women and newborns in a Spanish cohort (GESNEO-COVID) during the first wave.西班牙队列(GESNEO-COVID)在第一波疫情中对孕妇和新生儿的 SARS-CoV-2 感染情况。
BMC Pregnancy Childbirth. 2021 Apr 26;21(1):326. doi: 10.1186/s12884-021-03784-8.
6
Universal testing for severe acute respiratory syndrome coronavirus 2 in 2 Philadelphia hospitals: carrier prevalence and symptom development over 2 weeks.在费城的 2 家医院进行的严重急性呼吸综合征冠状病毒 2 通用检测:2 周内的携带者流行率和症状发展。
Am J Obstet Gynecol MFM. 2020 Nov;2(4):100226. doi: 10.1016/j.ajogmf.2020.100226. Epub 2020 Sep 11.
7
Prevalence, clinical features, and outcomes of SARS-CoV-2 infection in pregnant women with or without mild/moderate symptoms: Results from universal screening in a tertiary care center in Mexico City, Mexico.墨西哥城一家三级护理中心进行普遍筛查的结果:有或无症状轻症/中度症状的孕妇中 SARS-CoV-2 感染的流行率、临床特征和结局。
PLoS One. 2021 Apr 22;16(4):e0249584. doi: 10.1371/journal.pone.0249584. eCollection 2021.
8
Clinical and epidemiological aspects of SARS-CoV-2 infection among pregnant and postpartum women in Mozambique: a prospective cohort study.莫桑比克孕妇和产后妇女感染 SARS-CoV-2 的临床和流行病学特征:一项前瞻性队列研究。
Reprod Health. 2022 Jul 19;19(1):164. doi: 10.1186/s12978-022-01469-9.
9
The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: A national cohort study using the UK Obstetric Surveillance System (UKOSS).2020年3月至9月英国有症状和无症状SARS-CoV-2感染住院孕妇的发病率、特征及结局:一项使用英国产科监测系统(UKOSS)的全国队列研究
PLoS One. 2021 May 5;16(5):e0251123. doi: 10.1371/journal.pone.0251123. eCollection 2021.
10
Universal screening for SARS-CoV-2 in pregnant women at term admitted to an East London maternity unit.对入住伦敦东部妇产医院足月孕妇进行 SARS-CoV-2 的普遍筛查。
Eur J Obstet Gynecol Reprod Biol. 2020 Sep;252:444-446. doi: 10.1016/j.ejogrb.2020.07.035. Epub 2020 Jul 22.

引用本文的文献

1
Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia).德国弗兰肯地区通过逆转录聚合酶链反应评估的孕妇中严重急性呼吸综合征冠状病毒2的流行情况:情景研究(弗兰肯地区孕期及分娩时严重急性呼吸综合征冠状病毒2的流行情况)的初步结果
Geburtshilfe Frauenheilkd. 2022 Feb 11;82(2):226-234. doi: 10.1055/a-1727-9672. eCollection 2022 Feb.

本文引用的文献

1
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.SARS-CoV-2、SARS-CoV 和 MERS-CoV 的病毒载量动态、病毒脱落持续时间和传染性:系统评价和荟萃分析。
Lancet Microbe. 2021 Jan;2(1):e13-e22. doi: 10.1016/S2666-5247(20)30172-5. Epub 2020 Nov 19.
2
A blueprint for the implementation of a validated approach for the detection of SARS-Cov2 in clinical samples in academic facilities.学术机构中临床样本中检测新型冠状病毒(SARS-CoV2)的经验证方法的实施蓝图。
Wellcome Open Res. 2020 Oct 21;5:110. doi: 10.12688/wellcomeopenres.15937.2. eCollection 2020.
3
Performance Evaluation of the SAMBA II SARS-CoV-2 Test for Point-of-Care Detection of SARS-CoV-2.
SAMBA II SARS-CoV-2 检测试剂盒用于即时检测 SARS-CoV-2 的性能评估。
J Clin Microbiol. 2020 Dec 17;59(1). doi: 10.1128/JCM.01262-20.
4
Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis.无症状和出现症状前 SARS-CoV-2 感染的发生和传播潜力:一项实时系统评价和荟萃分析。
PLoS Med. 2020 Sep 22;17(9):e1003346. doi: 10.1371/journal.pmed.1003346. eCollection 2020 Sep.
5
Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike Variant.D614G 刺突变异株出现后,即时进行 SARS-CoV-2 的床边核酸和抗体联合检测
Cell Rep Med. 2020 Sep 22;1(6):100099. doi: 10.1016/j.xcrm.2020.100099. Epub 2020 Sep 1.
6
Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis.妊娠期 2019 年冠状病毒病的临床表现、危险因素和母婴围产结局:系统评价的实时更新和荟萃分析。
BMJ. 2020 Sep 1;370:m3320. doi: 10.1136/bmj.m3320.
7
Point of Care Nucleic Acid Testing for SARS-CoV-2 in Hospitalized Patients: A Clinical Validation Trial and Implementation Study.在院患者的即时护理点核酸检测 SARS-CoV-2:一项临床验证试验和实施研究。
Cell Rep Med. 2020 Aug 25;1(5):100062. doi: 10.1016/j.xcrm.2020.100062. Epub 2020 Jul 15.
8
Universal testing of patients and their support persons for severe acute respiratory syndrome coronavirus 2 when presenting for admission to labor and delivery at Mount Sinai Health System.西奈山医疗系统对前往产科住院分娩的患者及其陪护人员进行严重急性呼吸综合征冠状病毒2的普遍检测。
Am J Obstet Gynecol MFM. 2020 Aug;2(3):100147. doi: 10.1016/j.ajogmf.2020.100147. Epub 2020 May 22.
9
Outcomes of universal SARS-CoV-2 testing program in pregnant women admitted to hospital and the adjuvant role of lung ultrasound in screening: a prospective cohort study.住院孕妇普遍进行严重急性呼吸综合征冠状病毒2(SARS-CoV-2)检测项目的结果及肺部超声在筛查中的辅助作用:一项前瞻性队列研究
J Matern Fetal Neonatal Med. 2020 Nov;33(22):3820-3826. doi: 10.1080/14767058.2020.1798398. Epub 2020 Jul 28.
10
Universal screening for SARS-CoV-2 before labor admission during Covid-19 pandemic in Madrid.马德里在 COVID-19 大流行期间对临产孕妇进行 SARS-CoV-2 普筛
J Perinat Med. 2020 Nov 26;48(9):981-984. doi: 10.1515/jpm-2020-0236.